Ho‐Min Chen
- Strategy and Management top 2%
- International Business and FDI 9
- Innovation and Knowledge Management 8
- Accounting top 5%
- Oncology top 10%
-
- Bone health and osteoporosis research 9
-
- Health Systems, Economic Evaluations, Quality of Life 8
-
- Breast Cancer Treatment Studies 6
-
- Lymphoma Diagnosis and Treatment 6
-
- Hip and Femur Fractures 6
-
- Cervical Cancer and HPV Research 5
- Co-authors
- Chia‐Wen HsuYung-Chih LienSzu‐Yuan WuYu‐Yun ShaoAnn‐Lii ChengMei‐Shu LaiFei‐Yuan HsiaoChang-Yun Lu
- Cited by
- Strategy and ManagementBusiness and International ManagementManagement of Technology and Innovation
In The Last Decade
Ho‐Min Chen
92 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 122
- Strategy and Management 472
- Business and International Management 31
- Management of Technology and Innovation 95
- Accounting 150
- Oncology 320
Countries citing papers authored by Ho‐Min Chen
This map shows the geographic impact of Ho‐Min Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho‐Min Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho‐Min Chen more than expected).
Fields of papers citing papers by Ho‐Min Chen
This network shows the impact of papers produced by Ho‐Min Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho‐Min Chen. The network helps show where Ho‐Min Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ho‐Min Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 10 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 5 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 10 | |
| 11 | 2020 | 19 | |
| 12 | 2020 | 8 | |
| 13 | 2020 | 1 | |
| 14 | 2020 | 27 | |
| 15 | 2019 | 7 | |
| 16 | 2018 | 5 | |
| 17 | Abstract 15366: Comparative Effectiveness and Safety Between Reduced Dose Dabigatran, Reduced Dose Rivaroxaban and Warfarin Among Oldest Old Atrial Fibrillation Patients | 2017 | 1 |
| 18 | 2015 | 9 | |
| 19 | 2015 | 14 | |
| 20 | 2012 | 19 |
About Ho‐Min Chen
Ho‐Min Chen is a scholar working on Orthopedics and Sports Medicine, Geriatrics and Gerontology, Pathology and Forensic Medicine, Oncology and Strategy and Management, having authored 97 papers that have together received 1.5k indexed citations. Recurring topics across this work include Bone health and osteoporosis research (9 papers), International Business and FDI (9 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers), Innovation and Knowledge Management (8 papers), Breast Cancer Treatment Studies (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Hip and Femur Fractures (6 papers) and Cervical Cancer and HPV Research (5 papers). The work is most often cited by research in Strategy and Management (472 citations), Business and International Management (31 citations), Management of Technology and Innovation (95 citations), Accounting (150 citations) and Oncology (320 citations). Ho‐Min Chen has collaborated with scholars based in Taiwan, China and Japan. Frequent co-authors include Chia‐Wen Hsu, Yung-Chih Lien, Szu‐Yuan Wu, Yu‐Yun Shao, Ann‐Lii Cheng, Mei‐Shu Lai, Fei‐Yuan Hsiao, Chang-Yun Lu, Jiaqiang Zhang and Zhong‐Zhe Lin. Their work appears in journals such as Archives of Gerontology and Geriatrics, The Oncologist, International Business Review, American Journal of Cancer Research and Industrial Marketing Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.